The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

被引：0
|
作者：
Rachael L. DiSantostefano
Andrea K. Biddle
John P. Lavelle
机构：
[1] School of Public Health,Department of Health Policy and Administration
[2] University of North Carolina at Chapel Hill,Carolina Program in Healthcare and Aging Research
[3] Institute on Aging,Division of Urology
[4] University of North Carolina,undefined
[5] School of Medicine,undefined
[6] University of North Carolina,undefined
来源：
PharmacoEconomics | 2006年 / 24卷
关键词：
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; Urinary Symptom; Watchful Waiting; Utility Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 191
页数：20
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY AND SAFETY OF TERAZOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - COMMENT
    MCCONNELL, JD
    UROLOGY, 1995, 45 (03) : 413 - 413
  • [22] Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
    Chughtai, Bilal
    Elterman, Dean S.
    Lee, Richard
    Te, Alexis E.
    Kaplan, Steven A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 267 - 272
  • [23] Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia
    Shin, Hong Il
    Kim, Byung Hoon
    Chang, Hyuk Soo
    Park, Choal Hee
    Kim, Chun Il
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (04) : 265 - 268
  • [24] Long-term PSA trends following subcapsular prostatectomy for benign prostatic hyperplasia
    Espy, Paul G.
    Wind, Ante
    Wade, Burke
    Rowland, John
    Koo, Harty P.
    Grob, B. Mayer
    Klausner, Adam P.
    Despradel, Vidal M.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 494 - 494
  • [25] NEW TREATMENTS FOR BENIGN PROSTATIC HYPERPLASIA
    SKEPASTS, PK
    LEE, LM
    CANADIAN FAMILY PHYSICIAN, 1991, 37 : 935 - 939
  • [26] Cost-effectiveness of dutasteride in the treatment of benign prostatic hyperplasia (BPH)
    Kaczor, M.
    Pawlik, D.
    Becla, L.
    Dardzinski, W.
    Jasinska, A.
    Wojcik, R.
    Walczak, J.
    Nogas, G.
    Cel, M.
    Glogowski, C.
    Zespol-Instytutu, A.
    VALUE IN HEALTH, 2006, 9 (06) : A253 - A254
  • [27] COST-EFFECTIVENESS OF COMBINATION THERAPY FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Baker, T. M.
    Black, L.
    Bjerklund, Johansen T. E.
    VALUE IN HEALTH, 2009, 12 (07) : A309 - A309
  • [28] Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
    Chay, Junxing
    Tung, Joshua Yi Min
    Su, Rebecca Jade
    Aslim, Edwin Jonathan
    Wong, Callix
    Swan, Georgia
    Chua, Wei Jin
    Ho, Henry Sun Sien
    Finkelstein, Eric Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1269 - 1277
  • [29] Cost-effectiveness of Prostate Artery Embolization for Benign Prostatic Hyperplasia
    Gemmete, Joseph J.
    RADIOLOGY, 2023, 309 (03)
  • [30] Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
    Chay, J.
    Su, R.
    Tung, J. Y. M.
    Aslim, E. J.
    Wong, C.
    Swan, G.
    Chua, W. J.
    Ho, S. S. H.
    Finkelstein, E. A.
    EUROPEAN UROLOGY, 2023, 83 : S52 - S52
12345